HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gender, hyperlipidemia, and coronary artery disease.

Abstract
The importance of statins for the prevention and treatment of coronary artery disease (CAD), the recent paradoxical effects of hormone replacement therapy on prevention of CAD, and the role of nontraditional risk factors in CAD in women are examined.
AuthorsDale R Shepard, Hani Jneid, Holly L Thacker
JournalComprehensive therapy (Compr Ther) Vol. 29 Issue 1 Pg. 7-17 ( 2003) ISSN: 0098-8243 [Print] United States
PMID12701338 (Publication Type: Journal Article, Review)
Chemical References
  • Cardiotonic Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Selective Estrogen Receptor Modulators
  • Raloxifene Hydrochloride
Topics
  • Adult
  • Aged
  • Cardiotonic Agents (therapeutic use)
  • Coronary Artery Disease (complications, drug therapy, prevention & control)
  • Estrogen Replacement Therapy
  • Female
  • Health Behavior
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors (therapeutic use)
  • Hyperlipidemias (complications, drug therapy)
  • Life Style
  • Male
  • Middle Aged
  • Primary Prevention (methods)
  • Raloxifene Hydrochloride (therapeutic use)
  • Risk Factors
  • Selective Estrogen Receptor Modulators (therapeutic use)
  • Sex Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: